Tristel PLC
27 June 2007
For immediate release
27 June 2007
TRISTEL PLC
Trading update
Tristel plc ('Tristel'), the AIM listed provider of infection and contamination
control products, is pleased to provide a trading update.
Tristel has seen strong trading across the group and the Board expects operating
profits for the year ended 30 June 2007 to be slightly ahead of market
expectations. After the deduction of exceptional charges, Tristel anticipates
that profits before tax for the year will be broadly in line with market
expectations.
Since the announcement of its interim results in February, Tristel's core
domestic hospital business has not felt the impact of reduced NHS spending as
was experienced in Spring 2006. The introduction of new products, for example
Tristel's Fusion for Surfaces, and the diversification of its revenue stream
achieved by the acquisition of Tristel Technologies in June 2006, have
contributed to this greater stability. Tristel Technologies supplies
contamination control products in the areas of water treatment and food
processing.
Tristel plans to announce its final results on Monday 15th October 2007.
Contacts:
Tristel plc Parkgreen Communications Ltd
Paul Swinney Paul McManus
Chief Executive Tel: 020 7479 7933
Tel: 01638 721 500 Mob: 07980 541 893
Email:paul.mcmanus@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.